Roche's Genentech Defends Supply Shift For Top Cancer Drugs

BING NEWS:
  • Roche snags postsurgery FDA nod for Alecensa, eyes even broader lung cancer use
    The FDA has approved Alecensa as an adjuvant treatment following tumor resection in patients with early-stage, ALK-positive non-small cell lung cancer, Roche’s Genentech unit said on Thursday.
    04/19/2024 - 12:03 am | View Link
  • Roche's Genentech Gets FDA Approval for Lung-Cancer Treatment
    Roche Group-member Genentech said Thursday it had received regulatory approval for its treatment for patients with an early-stage form of lung cancer. The South San Francisco, Calif.-based company ...
    04/18/2024 - 10:48 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News